Niagen Bioscience (NAGE) Current Deferred Revenue (2020 - 2026)
Niagen Bioscience's Current Deferred Revenue was $329,000 in Q2 2026, up 8.6% from $303,000 a year earlier but down 13.4% from the prior quarter.
Powered by 
Analysis
Niagen Bioscience (NAGE) Current Deferred Revenue (2020 - 2026) Analysis & Trends
At the end of FY2025, Current Deferred Revenue at Niagen Bioscience came in at $399,000, down 34.7% from FY2024.
- Current Deferred Revenue shows a five-year compound annual growth rate of 7.5% (FY2020 to FY2025).
- In earlier years, Current Deferred Revenue was $611,000 in FY2024 (+213.3%), $195,000 in FY2023 (+24.2%), $157,000 in FY2022 (-2.5%) and $161,000 in FY2021 (-42.1%).
- Quarterly Current Deferred Revenue has moved between $141,000 (Q1 2022) and $611,000 (Q4 2024) over five years.
- Compared with a year earlier, Current Deferred Revenue was higher in five of the last eight quarters, with growth averaging 51.5%.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q4 2024 (growth of 213.3%); the worst was Q4 2021 (a decline of 42.1%).
- Per Business Quant data, NAGE's Current Deferred Revenue in the three quarters before Q2 2026 was $380,000 (Q1 2026), $399,000 (Q4 2025) and $292,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Procter & Gamble | 337.81 Bn | 293.80 Bn | 10.28 Bn |
| 2 | Colgate Palmolive | 68.01 Bn | 63.06 Bn | 3.30 Bn |
| 3 | Kenvue | 33.93 Bn | 29.54 Bn | 2.30 Bn |
| 4 | Estee Lauder Companies | 33.63 Bn | 21.70 Bn | 2.74 Bn |
| 5 | Kimberly Clark | 32.41 Bn | 29.73 Bn | 1.60 Bn |
| 6 | Church & Dwight | 22.35 Bn | 20.88 Bn | 693.90 Mn |
| 7 | Clorox | 9.80 Bn | 8.24 Bn | 804.00 Mn |
| 8 | e.l.f. Beauty | 5.95 Bn | 4.92 Bn | 398.84 Mn |
| 9 | Reynolds Consumer Products | 4.56 Bn | 4.22 Bn | 245.00 Mn |
| 10 | Niagen Bioscience | 230.41 Mn | -31.96 Mn | 19.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 329,000.00 |
| Mar 31, 2026 | 380,000.00 |
| Dec 31, 2025 | 399,000.00 |
| Sep 30, 2025 | 292,000.00 |
| Jun 30, 2025 | 303,000.00 |
| Mar 31, 2025 | 207,000.00 |
| Dec 31, 2024 | 611,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 156,000.00 |
| Mar 31, 2024 | 227,000.00 |
| Dec 31, 2023 | 195,000.00 |
| Sep 30, 2023 | 189,000.00 |
| Jun 30, 2023 | 166,000.00 |
| Mar 31, 2023 | 148,000.00 |
| Dec 31, 2022 | 157,000.00 |
| Sep 30, 2022 | 158,000.00 |
| Jun 30, 2022 | 173,000.00 |
| Mar 31, 2022 | 141,000.00 |
| Dec 31, 2021 | 161,000.00 |
| Sep 30, 2021 | 175,000.00 |
API Access
Niagen Bioscience Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NAGE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "NAGE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NAGE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();